c-Rel is crucial for the induction of Foxp3+ regulatory CD4 + T cells but not TH17 cells

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 671-676

  Visekruna, Alexander ^a   Huber, Magdalena ^a   Hellhund, Anne ^a   Bothur, Evita ^a   Reinhard, Katharina ^a   Bollig, Nadine ^a   Schmidt, Nicole ^b   Joeris, Thorsten ^b   Lohoff, Michael ^a   Steinhoff, Ulrich ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

C Rel; IL 2; TH17; Treg

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOREGULATION; INFLAMMATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; THYMUS;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-17; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-REL; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 77749245828     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940260     Document Type: Article

References (31)

1. Hayden, M. S. and Ghosh, S., Signaling to NF-kappaB. Genes Dev. 2004. 18: 2195-2224.
2. Pasparakis, M., Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009. 9: 778-788.
3. Beinke, S. and Ley, S. C., Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 2004. 382: 393-409.
4. Bonizzi, G. and Karin, M., The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004. 25: 280-288.
5. Karin, M. and Lin, A., NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002. 3: 221-227.
6. Sun, S. C. and Ley, S. C., New insights into NF-kappaB regulation and function. Trends Immunol. 2008. 29: 469-478.
7. Liou, H. C. and Hsia, C. Y., Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease. Bioessays 2003. 25: 767-780.
8. Vallabhapurapu, S. and Karin, M., Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009. 27: 693-733.
9. Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krahn, G., Bonizzi, G., Chen, Y. et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001. 293: 1495-1499.
10. Beinke, S., Belich, M. P., and Ley, S. C., The death domain of NF-kappa B1 p105 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 2002. 277: 24162-24168.
11. Heissmeyer, V., Krappmann, D., Hatada, E. N., and Scheidereit, C., Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and Ikappa-Balpha. Mol. Cell Biol. 2001. 21: 1024-1035.
12. Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S. E., Liou, H. C., Hunter, C., and Chen, Y. H., Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest 2002. 110: 843-850.
13. Ferch, U., zum Buschenfelde, C. M., Gewies, A., Wegener, E., Rauser, S., Peschel, C., Krappmann, D., and Ruland, J., MALT1 directs B cell receptorinduced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit. Nat. Immunol. 2007. 8: 984-991. 14 Liou, H. C., Sha, W. C., Scott, M. L. and Baltimore, D., Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 1994. 14: 5349-5359.
14. Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995. 9: 1965-1977.
15. Sallusto, F. and Lanzavecchia, A., Heterogeneity of CD4+memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 2009. 39: 2076-2082.
16. King, C., New insights into the differentiation and function of T follicular helper cells. Nat. Rev. Immunol. 2009. 9: 757-766.
17. Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y. H., and Dong, C., Bcl6 mediates the development of T follicular helper cells. Science 2009. 325: 1001-1005.
18. Reinhardt, R. L., Liang, H. E., and Locksley, R. M., Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 2009. 10: 385-393.
19. Schmidt-Supprian, M., Courtois, G., Tian, J., Coyle, A. J., Israel, A., Rajewsky, K. and Pasparakis, M., Mature T cells depend on signaling through the IKK complex. Immunity. 2003. 19: 377-389.
20. Schmidt-Supprian, M., Tian, J., Grant, E. P., Pasparakis, M., Maehr, R., Ovaa, H., Ploegh, H. L. et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. USA 2004. 101: 4566-4571.
21. Shevach, E. M., Mechanisms of foxp3+T regulatory cell-mediated suppression. Immunity. 2009. 30: 636-645.
22. Curotto de Lafaille, M. A. and Lafaille, J. J., Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity. 2009. 30: 626-635.
23. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B. et al., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007. 26: 371-381.
24. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y. et al., TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008. 453: 236-240.
25. D'Cruz, L. M. and Klein, L., Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 2005. 6: 1152-1159.
26. Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R. and Farrar, M. A., IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+regulatory T cells. J. Immunol. 2007. 178: 280-290.
27. Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., Arpaia, E. et al., The development of inflammatory T(H)-17 cells requires interferon-regulatory factor. Nat. Immunol. 2007. 8: 958-966.
28. Huber, M., Brustle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., von, L. E. and Lohoff, M., IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008. 105: 20846-20851.
29. Grumont, R. J. and Gerondakis, S., Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferonregulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 2000. 191: 1281-1292.
30. Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A., et al., c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J. Exp. Med. 2009. 206: 3001-3014.
31. Huber, M., Steinwald, V., Guralnik, A., Brustle, A., Kleemann, P., Rosenplanter, C., Decker, T. and Lohoff, M., IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 2008. 20: 223-234.